As described above, multiple studies indicate that TET2 is the most frequently mutated gene in AITL and that mutations in RHOA (G17V) frequently coincides with TET2 mutations in patients44,45. The gene discussed is TET2; the disease is angioimmunoblastic T-cell lymphoma.